Multiplier Holdings Launches With $27.5 Million in Funding to Accelerate the AI Journey for Professional Services Firms
- 23 06 2025
- |
S*BIO Initiates Canadian Phase 2 Clinical Trial of Oral Histone Deacetylase(HDAC) Inhibitor SB939
Related Posts
Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management
- 05 06 2025
- |
Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy
- 03 06 2025
- |
Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy
- 20 05 2025
- |
VFlowTech Secures USD $20.5 Million in its Latest Fundraising to Scale Long-Duration Energy Storage and Strengthen AI-Driven Energy Management
- 16 05 2025
- |
